Global Ocular Neuromodulation Device 麻豆原创 Research Report 2025

Publication ID:

PB503250410

Publication Date:

March 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Ocular Neuromodulation Device was valued at US$ 110 million in the year 2024 and is projected to reach a revised size of US$ 301 million by 2031, growing at a CAGR of 15.6% during the forecast period.
Ocular neuromodulation devices are medical devices that regulate the transmission of visual signals by electrically stimulating the ocular nerves or retinal areas. They deliver electrical signals to the optic nerve or retina through implanted electrodes or microstimulators to improve vision or treat visual impairment caused by nerve damage, retinal degeneration, etc. These devices are often used to treat patients who are blind or severely visually impaired, providing a new treatment option, especially when traditional treatments are ineffective.
North American market for Ocular Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ocular Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Ocular Neuromodulation Device include Bionic Sight, Monash Vision Group, Neuralink, Precision Neuroscience, Lambda Vision, Chaomu Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ocular Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Neuromodulation Device.
The Ocular Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ocular Neuromodulation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bionic Sight
Monash Vision Group
Neuralink
Precision Neuroscience
Lambda Vision
Chaomu Technology
Segment by Type
Retinal Nerve Stimulator
Optic Nerve Stimulator
Segment by Application
General Hospital
Specialized Hospital
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ocular Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Ocular Neuromodulation Device 麻豆原创 Overview
1.1 Product Definition
1.2 Ocular Neuromodulation Device by Type
1.2.1 Global Ocular Neuromodulation Device 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Retinal Nerve Stimulator
1.2.3 Optic Nerve Stimulator
1.3 Ocular Neuromodulation Device by Application
1.3.1 Global Ocular Neuromodulation Device 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 General Hospital
1.3.3 Specialized Hospital
1.4 Global Ocular Neuromodulation Device 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Ocular Neuromodulation Device Revenue 2020-2031
1.4.2 Global Ocular Neuromodulation Device Sales 2020-2031
1.4.3 Global Ocular Neuromodulation Device 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ocular Neuromodulation Device 麻豆原创 Competition by Manufacturers
2.1 Global Ocular Neuromodulation Device Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Ocular Neuromodulation Device Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Ocular Neuromodulation Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ocular Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ocular Neuromodulation Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ocular Neuromodulation Device, Product Type & Application
2.7 Global Key Manufacturers of Ocular Neuromodulation Device, Date of Enter into This Industry
2.8 Global Ocular Neuromodulation Device 麻豆原创 Competitive Situation and Trends
2.8.1 Global Ocular Neuromodulation Device 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Ocular Neuromodulation Device Players 麻豆原创 Share by Revenue
2.8.3 Global Ocular Neuromodulation Device Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ocular Neuromodulation Device 麻豆原创 Scenario by Region
3.1 Global Ocular Neuromodulation Device 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ocular Neuromodulation Device Sales by Region: 2020-2031
3.2.1 Global Ocular Neuromodulation Device Sales by Region: 2020-2025
3.2.2 Global Ocular Neuromodulation Device Sales by Region: 2026-2031
3.3 Global Ocular Neuromodulation Device Revenue by Region: 2020-2031
3.3.1 Global Ocular Neuromodulation Device Revenue by Region: 2020-2025
3.3.2 Global Ocular Neuromodulation Device Revenue by Region: 2026-2031
3.4 North America Ocular Neuromodulation Device 麻豆原创 Facts & Figures by Country
3.4.1 North America Ocular Neuromodulation Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ocular Neuromodulation Device Sales by Country (2020-2031)
3.4.3 North America Ocular Neuromodulation Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ocular Neuromodulation Device 麻豆原创 Facts & Figures by Country
3.5.1 Europe Ocular Neuromodulation Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ocular Neuromodulation Device Sales by Country (2020-2031)
3.5.3 Europe Ocular Neuromodulation Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ocular Neuromodulation Device 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Ocular Neuromodulation Device 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ocular Neuromodulation Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Ocular Neuromodulation Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ocular Neuromodulation Device 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Ocular Neuromodulation Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ocular Neuromodulation Device Sales by Country (2020-2031)
3.7.3 Latin America Ocular Neuromodulation Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Ocular Neuromodulation Device 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Ocular Neuromodulation Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ocular Neuromodulation Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ocular Neuromodulation Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ocular Neuromodulation Device Sales by Type (2020-2031)
4.1.1 Global Ocular Neuromodulation Device Sales by Type (2020-2025)
4.1.2 Global Ocular Neuromodulation Device Sales by Type (2026-2031)
4.1.3 Global Ocular Neuromodulation Device Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Ocular Neuromodulation Device Revenue by Type (2020-2031)
4.2.1 Global Ocular Neuromodulation Device Revenue by Type (2020-2025)
4.2.2 Global Ocular Neuromodulation Device Revenue by Type (2026-2031)
4.2.3 Global Ocular Neuromodulation Device Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Ocular Neuromodulation Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ocular Neuromodulation Device Sales by Application (2020-2031)
5.1.1 Global Ocular Neuromodulation Device Sales by Application (2020-2025)
5.1.2 Global Ocular Neuromodulation Device Sales by Application (2026-2031)
5.1.3 Global Ocular Neuromodulation Device Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Ocular Neuromodulation Device Revenue by Application (2020-2031)
5.2.1 Global Ocular Neuromodulation Device Revenue by Application (2020-2025)
5.2.2 Global Ocular Neuromodulation Device Revenue by Application (2026-2031)
5.2.3 Global Ocular Neuromodulation Device Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Ocular Neuromodulation Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bionic Sight
6.1.1 Bionic Sight Company Information
6.1.2 Bionic Sight Description and Business Overview
6.1.3 Bionic Sight Ocular Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bionic Sight Ocular Neuromodulation Device Product Portfolio
6.1.5 Bionic Sight Recent Developments/Updates
6.2 Monash Vision Group
6.2.1 Monash Vision Group Company Information
6.2.2 Monash Vision Group Description and Business Overview
6.2.3 Monash Vision Group Ocular Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Monash Vision Group Ocular Neuromodulation Device Product Portfolio
6.2.5 Monash Vision Group Recent Developments/Updates
6.3 Neuralink
6.3.1 Neuralink Company Information
6.3.2 Neuralink Description and Business Overview
6.3.3 Neuralink Ocular Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Neuralink Ocular Neuromodulation Device Product Portfolio
6.3.5 Neuralink Recent Developments/Updates
6.4 Precision Neuroscience
6.4.1 Precision Neuroscience Company Information
6.4.2 Precision Neuroscience Description and Business Overview
6.4.3 Precision Neuroscience Ocular Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Precision Neuroscience Ocular Neuromodulation Device Product Portfolio
6.4.5 Precision Neuroscience Recent Developments/Updates
6.5 Lambda Vision
6.5.1 Lambda Vision Company Information
6.5.2 Lambda Vision Description and Business Overview
6.5.3 Lambda Vision Ocular Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lambda Vision Ocular Neuromodulation Device Product Portfolio
6.5.5 Lambda Vision Recent Developments/Updates
6.6 Chaomu Technology
6.6.1 Chaomu Technology Company Information
6.6.2 Chaomu Technology Description and Business Overview
6.6.3 Chaomu Technology Ocular Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Chaomu Technology Ocular Neuromodulation Device Product Portfolio
6.6.5 Chaomu Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ocular Neuromodulation Device Industry Chain Analysis
7.2 Ocular Neuromodulation Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ocular Neuromodulation Device Production Mode & Process Analysis
7.4 Ocular Neuromodulation Device Sales and 麻豆原创ing
7.4.1 Ocular Neuromodulation Device Sales Channels
7.4.2 Ocular Neuromodulation Device Distributors
7.5 Ocular Neuromodulation Device Customer Analysis
8 Ocular Neuromodulation Device 麻豆原创 Dynamics
8.1 Ocular Neuromodulation Device Industry Trends
8.2 Ocular Neuromodulation Device 麻豆原创 Drivers
8.3 Ocular Neuromodulation Device 麻豆原创 Challenges
8.4 Ocular Neuromodulation Device 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bionic Sight
Monash Vision Group
Neuralink
Precision Neuroscience
Lambda Vision
Chaomu Technology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.